Skip to content

PPPharmacy: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

PPPharmacy

BE 0765.736.905
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€49,925
2024 · €76,898-€26,973
Equity
€84,763
2024 · €224,114-€139,351
Cash
€65,933
2024 · €219,034-€153,101
Balance sheet total
€106,768
2024 · €249,231-€142,463

Largest movements

2024 to 2025
Assets
  • Cash -€153,101

    down €153,101 (-69.9%), from €219,034 to €65,933

    mainly Contributions, distributions and other (-€189,276) and Receivables within one year (-€16,389)

  • Receivables within one year +€16,389

    up €16,389 (+88.1%), from €18,595 to €34,984

    of which Trade receivables: +€10,149

  • Tangible fixed assets -€6,072

    down €6,072 (-60.8%), from €9,991 to €3,919

    of which Leasing and similar rights: -€5,225

Equity and liabilities
  • Reserves -€139,351

    down €139,351 (-63.6%), from €219,114 to €79,763

  • Tax, wage and social debts +€5,766

    up €5,766 (+65.0%), from €8,872 to €14,638

    of which Taxes: +€4,086

  • Other debts -€4,603

    down €4,603 (-84.8%), from €5,430 to €827

  • Debts after one year -€3,665

    no longer reported in 2025 (was €3,665)

Income statement
  • Gross operating margin -€33,483

    down €33,483 (-32.1%), from €104,314 to €70,831

  • Taxes -€6,570

    down €6,570 (-33.1%), from €19,848 to €13,278

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €76,898
Gross operating margin -€33,483
Depreciation +€247
Other operating charges -€281
Financial income -€23
Financial charges -€4
Taxes +€6,570
Result 2025 €49,925

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€41,009
Investment €0
Financing -€194,111
Cash 2024 €219,034
Net result for the year +€49,925
Depreciation +€6,072
Receivables within one year -€16,389
Deferred charges and accrued income -€321
Trade debts +€560
Tax, wage and social debts +€5,766
Other debts -€4,603
Debts after one year -€3,665
Current portion of long-term debt -€1,170
Contributions, distributions and other -€189,276
Cash 2025 €65,933
Every line side by side 40 lines
Line Code 2024 2025 Change %
Total assets 20/58 €249,231 €106,768 -€142,463 -57.2%
Fixed assets 21/28 €9,991 €3,919 -€6,072 -60.8%
Tangible fixed assets 22/27 €9,991 €3,919 -€6,072 -60.8%
Furniture and vehicles 24 €848 - -€848
Leasing and similar rights 25 €9,143 €3,919 -€5,225 -57.1%
Current assets 29/58 €239,240 €102,849 -€136,391 -57.0%
Amounts receivable within one year 40/41 €18,595 €34,984 +€16,389 +88.1%
Trade receivables 40 €15,613 €25,762 +€10,149 +65.0%
Other amounts receivable 41 €2,982 €9,222 +€6,240 +209.3%
Cash at bank and in hand 54/58 €219,034 €65,933 -€153,101 -69.9%
Deferred charges and accrued income 490/1 €1,611 €1,932 +€321 +19.9%
Total equity and liabilities 10/49 €249,231 €106,768 -€142,463 -57.2%
Equity 10/15 €224,114 €84,763 -€139,351 -62.2%
Contributions 10/11 €5,000 €5,000 = 0.0%
Reserves 13 €219,114 €79,763 -€139,351 -63.6%
Distributable reserves 133 €219,114 €79,763 -€139,351 -63.6%
Amounts payable 17/49 €25,118 €22,005 -€3,113 -12.4%
Amounts payable after more than one year 17 €3,665 - -€3,665
Financial debts 170/4 €3,665 - -€3,665
Amounts payable within one year 42/48 €21,177 €21,730 +€553 +2.6%
Current portion of amounts payable after more than one year 42 €4,835 €3,665 -€1,170 -24.2%
Trade debts 44 €2,039 €2,599 +€560 +27.5%
Suppliers 440/4 €2,039 €2,599 +€560 +27.5%
Taxes, remuneration and social security 45 €8,872 €14,638 +€5,766 +65.0%
Taxes 450/3 €5,983 €10,068 +€4,086 +68.3%
Remuneration and social security 454/9 €2,890 €4,570 +€1,680 +58.1%
Other amounts payable 47/48 €5,430 €827 -€4,603 -84.8%
Accrued charges and deferred income 492/3 €275 €275 = 0.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €6,320 €6,072 -€247 -3.9%
Other operating charges 640/8 €1,037 €1,318 +€281 +27.1%
Gross operating margin 9900 €104,314 €70,831 -€33,483 -32.1%
Operating profit (loss) 9901 €96,957 €63,440 -€33,517 -34.6%
Financial income 75/76B €27 €5 -€23 -83.1%
Recurring financial income 75 €27 €5 -€23 -83.1%
Financial charges 65/66B €239 €242 +€4 +1.5%
Recurring financial charges 65 €239 €242 +€4 +1.5%
Profit (loss) for the period before taxes 9903 €96,746 €63,203 -€33,543 -34.7%
Income taxes 67/77 €19,848 €13,278 -€6,570 -33.1%
Profit (loss) for the period 9904 €76,898 €49,925 -€26,973 -35.1%
Profit (loss) for the period to be appropriated 9905 €76,898 €49,925 -€26,973 -35.1%

Source: filed annual accounts (NBB), fiscal years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.